Champions Oncology Inc (CSBR)
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
$4.830.00%
Close 2026-11-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · CSBR
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -87.4% |
| Our one-year growth estimate | diamond |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| 11.0% |
Growth built into the price is above our model estimate.
The price assumes 98.4 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Worth watching into the next print: this name is a smaller-cap name (higher miss base rate) and has been missing across recent quarters. A fundamental tilt, not a price call.
Model as of 2026-11-04 · Compared with 66 industry peers
CSBR — earnings miss
Dated 2026-09-10
in this Current Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Why it matters: Revenue grew 8.8% in Q1, led by research services and data licenses. Another gain would show that growth is continuing.
Supportive ifIn the December 21, 2026 results, revenue is above $15.2 million and grows more than 8.8% year over year.
Worry ifRevenue is at or below $15.2 million, or year-over-year growth is 0% or less.
Why it matters: Data license revenue helped lift Q1 revenue. FY2026 growth came despite a prior-year license deal that did not repeat, so new gains would show broader demand.
Supportive ifThe next report says data license revenue rose from a year ago. It names at least one new or expanded customer license.
Worry ifThe next report says data license revenue fell from a year ago, or reports no new or larger customer license.
Why it matters: Cash fell to $4.4 million, with $492,000 used in operations during Q1. Lower cash use would give the company more room to fund its growth work.
Supportive ifThe next report shows cash from operations at zero or above, or cash above $4.4 million with no debt.
Worry ifThe next report shows cash from operations below -$492,000, or cash below $4.0 million.
Why it matters: Adjusted EBITDA was $671,000 in Q1, while sales and marketing costs rose 66.6%. Positive results would show the added sales spend can be covered.
Supportive ifThe next report shows adjusted EBITDA above $0. Sales and marketing costs are no higher than $3.1 million.
Worry ifThe next report shows adjusted EBITDA at or below $0. Or sales and marketing costs above $3.1 million, with no higher revenue.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$185 on $10,000 · ±1.8% | How much price usually moves either way. |
| Bad day | $479 loss on $10,000 · 4.8% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $3,987 loss on $10,000 · 39.9% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.